9 /100
LOW RISK
Score updated Jul 13, 2026

EXPE — Expedia Group, Inc. Dilution Risk Tracker

Track EXPE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track EXPE — Get alerts when the score changes →

As of July 13, 2026, Expedia Group, Inc. (EXPE) has a DilutionWatch DilutionScore of 9/100, rated LOW dilution risk. Expedia Group, Inc. has a market capitalization of $27.10B, 114.48M shares outstanding, 1106 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
16
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for EXPE.
🔔 Track EXPE — Get forecast alerts →

💹 Market Data

Market Cap$27.10B
Shares Outstanding114.48M
Float113.59M
Cash$5.79B
Debt$4.47B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 14.6% shares (2026Q1 vs prior)
1106 institutional holders · 144.02M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 15.20M shares
#2 BlackRock, Inc. 10.50M shares
#3 BARCLAYS PLC 8.43M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest9.38M
Days to Cover5.0
% of Float8.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
4 INSIDER TRANSACTION Apr 15, 2026
8-K 8K EVENT Apr 10, 2026
4 INSIDER TRANSACTION Apr 02, 2026
4 INSIDER TRANSACTION Apr 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for EXPE Shareholders

Expedia Group, Inc. (EXPE) has a DilutionScore of 9/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for EXPE shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for EXPE in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for EXPE alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track EXPE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EXPE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for EXPE
📊 EXPE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 EXPE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.